Your browser doesn't support javascript.
loading
Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
Clinical Psychopharmacology and Neuroscience ; : 246-252, 2018.
Artigo em Inglês | WPRIM | ID: wpr-716306
ABSTRACT
Autism spectrum disorder is a rapidly increasing heterogeneous neurodevelopmental syndrome, remarked by persistent deficit in social communication, and restricted, repetitive patterns of behavior and interest. Lately, maternal immune activation and micgroglial dysfunction in the developing brain have been gaining mounting evidence and leading to studies of various novel agents as potential treatment options. A few immunomodulatory treatment options—luteolin, minocycline, suramin, vitamin D, gut microbiota—are discussed in the current article, regarding the current understanding of their mechanisms and evidence for potential clinical use. More studies are warranted to understand their exact mechanisms of action and to verify efficacy and safety in human subjects.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Transtorno Autístico / Suramina / Vitamina D / Encéfalo / Microglia / Imunomodulação / Transtorno do Espectro Autista / Minociclina Limite: Humanos Idioma: Inglês Revista: Clinical Psychopharmacology and Neuroscience Ano de publicação: 2018 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Transtorno Autístico / Suramina / Vitamina D / Encéfalo / Microglia / Imunomodulação / Transtorno do Espectro Autista / Minociclina Limite: Humanos Idioma: Inglês Revista: Clinical Psychopharmacology and Neuroscience Ano de publicação: 2018 Tipo de documento: Artigo